Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Okada

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2021
Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trialYuki Kyoda, Manabu Okada, Ryuichi Kato, et al.
Frontiers in Immunology|January 26, 2026
Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplantTakahisa Hiramitsu, Yuki Shimamoto, Tomoki Himeno, et al.
International Immunology|June 8, 2018
Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation/antibody production after kidney transplantationKenta Iwasaki, Nana Kitahata, Takahisa Hiramitsu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 19, 2007
Toxicogenomics of drug-induced hemolytic anemia by analyzing gene expression profiles in the spleenMasatomo Rokushima, Kazuo Omi, Kae Imura, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 8, 2021
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled TrialMakoto Tsujita, Yohei Doi, Yoshitsugu Obi, et al.
Kidney International Reports|May 6, 2024
Impact of Age 70 years or Older on Donors for Living-Donor Kidney TransplantationTakahisa Hiramitsu, Tomoki Himeno, Yuki Hasegawa, et al.
Iscience|September 9, 2024
Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditionsTatsuya Yamazaki, Kenta Iwasaki, Susumu Tomono, et al.
Human Immunology|April 4, 2018
Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejectionTakayuki Yamamoto, Kenta Iwasaki, Kenta Murotani, et al.
Frontiers in Immunology|April 26, 2021
Clinical Significance of Shared T Cell Epitope Analysis in Early <i>De Novo</i> Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope AnalysisToshihide Tomosugi, Kenta Iwasaki, Shintaro Sakamoto, et al.
Clinical Transplantation|August 10, 2017
Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatmentManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2021
Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trialYuki Kyoda, Manabu Okada, Ryuichi Kato, et al.
Frontiers in Immunology|January 26, 2026
Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplantTakahisa Hiramitsu, Yuki Shimamoto, Tomoki Himeno, et al.
International Immunology|June 8, 2018
Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation/antibody production after kidney transplantationKenta Iwasaki, Nana Kitahata, Takahisa Hiramitsu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 19, 2007
Toxicogenomics of drug-induced hemolytic anemia by analyzing gene expression profiles in the spleenMasatomo Rokushima, Kazuo Omi, Kae Imura, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 8, 2021
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled TrialMakoto Tsujita, Yohei Doi, Yoshitsugu Obi, et al.
Kidney International Reports|May 6, 2024
Impact of Age 70 years or Older on Donors for Living-Donor Kidney TransplantationTakahisa Hiramitsu, Tomoki Himeno, Yuki Hasegawa, et al.
Iscience|September 9, 2024
Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditionsTatsuya Yamazaki, Kenta Iwasaki, Susumu Tomono, et al.
Human Immunology|April 4, 2018
Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejectionTakayuki Yamamoto, Kenta Iwasaki, Kenta Murotani, et al.
Frontiers in Immunology|April 26, 2021
Clinical Significance of Shared T Cell Epitope Analysis in Early <i>De Novo</i> Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope AnalysisToshihide Tomosugi, Kenta Iwasaki, Shintaro Sakamoto, et al.
Clinical Transplantation|August 10, 2017
Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatmentManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Pageof 10